Nuvectis Pharma, Inc. (NVCT) Tops Q1 EPS by 15c

Nuvectis Pharma, Inc. (NASDAQ: NVCT) reported Q1 EPS of ($0.25), $0.15 better than the analyst estimate of ($0.40).

For earnings history and earnings-related data on Nuvectis Pharma, Inc. (NVCT) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• S&P 500 may pull back before midterms, but Citi says buy the dip
• UBS Upgrades Apollo Tyres (APTY:IN) to Buy